In this blog, Lana El-Etr examines the legal and ethical implications of patenting fully synthetic minimal cells, organisms engineered with only the essential genes for life. While a few Supreme Court decisions provide some guidance, this blog argues for updated patent standards that clearly define what qualifies as synthetic and patentable, guard against monopolization of foundational biological tools, and promote equitable access to medical and biotechnological advancements.
OK, Computer: The Dangers of AI Chatbots
The increased use of AI chatbots for both business and personal use has presented a slew of problems. In this blog, Jen Neal explores the problems that AI chatbots have caused consumers and businesses alike. New court decisions and pending caselaw appear to indicate that premature, unmonitored rollouts of new technology can have serious consequences.
Who Owns Your DNA? The Privacy Nightmare of At-Home Genetic Tests
In this article, Lana El-Etr explores the legal and ethical risks of direct-to-consumer genetic testing, highlighting gaps in data privacy and intellectual property laws. She calls for stronger regulations to protect consumer data, ensure informed consent, and prevent monopolization of genetic information.
Dr. AI; How AI is Affecting the Medical Industry
In this article, Sarah Saadeh discusses how AI is shaking up the medical field and while helping in some processes is also causing commotion with concerns of harm to patients and breaching the duty of care, potential physician and insurance liability and what the regulatory landscape looks like right now advocates for Human-in-the-Loop regulation.